retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial hormone receptor for metabolic dysfunction-associated steatotic liver disease: a randomized 2a retatrutide triple agonist phase 2
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


























